Clinical Trial Update: Effectiveness of Botox on Reducing Rest Tremor in Parkinson's Disease [Phase 2]

View source ↗

Summary

Phase 2 clinical trial assessing the effectiveness of Botulinum toxin (Botox) to reduce rest tremor in Parkinson's disease has completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Parkinson Disease

Drugs mentioned

• Botox (OnabotulinumtoxinA)

Snippet

Sponsor: University of North Carolina, Chapel Hill | Conditions: Parkinson Disease | Phase 2 | Status: COMPLETED | Results posted: 2020-08-17